This is a patient-run survey to explore why phenelzine (Nardil) works well for some people and not for others, particularly in treating depression and anxiety.
WHO SHOULD PARTICIPATE: This survey is only for people who are 18 years or older and are either:
1. Currently taking phenelzine at a therapeutic dose for at least 3 months, or who are
2. Not currently taking phenelzine, but have taken it in the past at a therapeutic dose for at least 3 months.
If any of these criteria do not apply to you, please close this page now.
Anonymity: This survey is 100% anonymous.
Basic demographic and treatment-related data will be collected for aggregate analysis. No identifying info is required unless you choose to provide it.
At the end of the survey, you will be given the option to share your contact info for optional follow-up surveys, but this is not required.
Timing: This survey should take no longer than 5 minutes to complete.
Terminology: For clarity, please note that throughout this survey we will use the term “phenelzine” to refer to Nardil.
Questions? If you have any questions about this survey, email:
[email protected] If you qualify as specified above, please press the button below to proceed.